A Phase 3 Study to Evaluate the Efficacy and Safety of Pimecrolimus 0.3% Ophthalmic Ointment
Clinical trial NCT06400511 · TERMINATED
Trial details
- NCT number
- NCT06400511
- Sponsor
- Famy Life Sciences, a Viatris Company
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-04-22
- Primary completion
- 2025-09-09
- Enrollment
- 477
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.